Frontiers
US$ 21.28
glp 1 eczema A Closer Look at the Dermatological Profile of GLP-1 Agonists Beyond Weight Loss: Clinical Perspectives
Description
In recent years, the drugs have transitioned from being solely for type 2 diabetes treatment to increasing use as weight loss drugs, with Novo Nordisks Wegovy and Eli Lillys Zepbound being developed specifically for that purpose
A few small clinical studies and observational reports indicate that individuals treated with GLP1 RAs may report reduced alcohol cravings and lower consumption levels
For most people, fatigue related to semaglutide is temporary and improves as the body adjusts
Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, et al
